These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21077849)

  • 41. Metformin promotes differentiation of human bone marrow derived mesenchymal stem cells into osteoblast via GSK3β inhibition.
    Ma J; Zhang ZL; Hu XT; Wang XT; Chen AM
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7962-7968. PubMed ID: 30536344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts.
    Vogt A; Qian Y; McGuire TF; Hamilton AD; Sebti SM
    Oncogene; 1996 Nov; 13(9):1991-9. PubMed ID: 8934546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitors.
    Morgan MA; Wegner J; Aydilek E; Ganser A; Reuter CW
    Leukemia; 2003 Aug; 17(8):1508-20. PubMed ID: 12886237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
    Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
    Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro.
    Rehni AK; Singh TG
    Neuropharmacology; 2013 Aug; 71():19-26. PubMed ID: 23415632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells.
    Bolick SC; Landowski TH; Boulware D; Oshiro MM; Ohkanda J; Hamilton AD; Sebti SM; Dalton WS
    Leukemia; 2003 Feb; 17(2):451-7. PubMed ID: 12592346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.
    Berndt N; Sebti SM
    Nat Protoc; 2011 Oct; 6(11):1775-91. PubMed ID: 22036881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells.
    Gong Z; Wezeman FH
    Alcohol Clin Exp Res; 2004 Mar; 28(3):468-79. PubMed ID: 15084905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
    Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
    Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
    Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.
    Wu Y; Xia L; Zhou Y; Xu Y; Jiang X
    Cell Prolif; 2015 Jun; 48(3):375-84. PubMed ID: 25867119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteogenic differentiation of mesenchymal stem cells could be enhanced by strontium.
    Yang F; Tu J; Yang D; Li G; Cai L; Wang L
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():823-6. PubMed ID: 21096310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications.
    Caraglia M; Budillon A; Tagliaferri P; Marra M; Abbruzzese A; Caponigro F
    Curr Drug Targets; 2005 May; 6(3):301-23. PubMed ID: 15857290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
    Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
    J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for Aryl hydrocarbon Receptor-Mediated Inhibition of Osteoblast Differentiation in Human Mesenchymal Stem Cells.
    Watson ATD; Nordberg RC; Loboa EG; Kullman SW
    Toxicol Sci; 2019 Jan; 167(1):145-156. PubMed ID: 30203000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
    Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
    J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells.
    Chang CH; Wang CZ; Chang JK; Hsu CY; Ho ML
    PLoS One; 2014; 9(8):e105705. PubMed ID: 25157615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.